NO923673L - Nye nitrogencykliske ligander, fremgangsmaate for deres fremstilling, polymetallkomplekser og et diagnostisk og terapeutisk preparat - Google Patents

Nye nitrogencykliske ligander, fremgangsmaate for deres fremstilling, polymetallkomplekser og et diagnostisk og terapeutisk preparat

Info

Publication number
NO923673L
NO923673L NO92923673A NO923673A NO923673L NO 923673 L NO923673 L NO 923673L NO 92923673 A NO92923673 A NO 92923673A NO 923673 A NO923673 A NO 923673A NO 923673 L NO923673 L NO 923673L
Authority
NO
Norway
Prior art keywords
preparation
ligands
diagnostic
image
nitrogencyclic
Prior art date
Application number
NO92923673A
Other languages
English (en)
Other versions
NO923673D0 (no
Inventor
Olivier Rousseaux
Michel Schaefer
Anne Bouillot
Dominique Meyer
Original Assignee
Guerbet Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet Sa filed Critical Guerbet Sa
Publication of NO923673D0 publication Critical patent/NO923673D0/no
Publication of NO923673L publication Critical patent/NO923673L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Ligander med formel (I) hvori B er en gruppe (a) hvori W er en gruppe (3) eller (T) hvori X og Z er en heterosyklisk forbindelse. Oppfinnelsen vedrcreren også mono- eller poly-metallkomplek- ser som er dannet av de nevnte ligander med metallioner valgt fra lantanidioner, overgangsmetallioner, barium, vismut, bly og radioisotopene 99mTc, 111In, 90Y, 64Cu og 169Yb, og fysiologisk tålbare salter derav. Saltene av disse komplekser kan anvendes som diagnostiske og terapeutiske midler i forbindelse med NMR avbildning og røntgenfotografering, som kjemiske skift-midler in vivo, og innen nukleærmedisin.
NO92923673A 1991-01-24 1992-09-22 Nye nitrogencykliske ligander, fremgangsmaate for deres fremstilling, polymetallkomplekser og et diagnostisk og terapeutisk preparat NO923673L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9100811A FR2672051B1 (fr) 1991-01-24 1991-01-24 Nouveaux ligands macrocycliques azotes, procede de preparation, complexes polymetalliques, composition de diagnostic et therapeutique.
PCT/FR1992/000057 WO1992012978A1 (fr) 1991-01-24 1992-01-22 Nouveaux ligands macrocycliques azotes, procede de preparation, complexes polymetalliques, composition de diagnostic et therapeutique

Publications (2)

Publication Number Publication Date
NO923673D0 NO923673D0 (no) 1992-09-22
NO923673L true NO923673L (no) 1992-11-24

Family

ID=9409017

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923673A NO923673L (no) 1991-01-24 1992-09-22 Nye nitrogencykliske ligander, fremgangsmaate for deres fremstilling, polymetallkomplekser og et diagnostisk og terapeutisk preparat

Country Status (18)

Country Link
US (1) US5374416A (no)
EP (1) EP0499501B1 (no)
JP (1) JPH0735381B2 (no)
KR (1) KR960014355B1 (no)
AT (1) ATE169916T1 (no)
AU (1) AU650325B2 (no)
CA (1) CA2078983A1 (no)
CZ (1) CZ281225B6 (no)
DE (1) DE69226669T2 (no)
FR (1) FR2672051B1 (no)
HU (1) HUT70023A (no)
IE (1) IE920204A1 (no)
IL (1) IL100717A (no)
MX (1) MX9200319A (no)
NO (1) NO923673L (no)
NZ (1) NZ241356A (no)
WO (1) WO1992012978A1 (no)
ZA (1) ZA92470B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69024826T2 (de) * 1989-02-10 1996-06-27 Celltech Therapeutics Ltd Aza-Macrozyklen und Verfahren zu deren Herstellung
US5645818A (en) * 1989-03-24 1997-07-08 Guerbet S.A. Diagnostic compositions comprising a complex formed by a nitrogenous macrocyclic ligand with metal ions
GB9126677D0 (en) 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds
US5462725A (en) * 1993-05-06 1995-10-31 The Dow Chemical Company 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
DE4318369C1 (de) * 1993-05-28 1995-02-09 Schering Ag Verwendung von makrocyclischen Metallkomplexen als Temperatursonden
US6693190B1 (en) 1994-05-11 2004-02-17 Bracco International B.V. Enhanced relaxivity monomeric and multimeric compounds
US20030017941A1 (en) * 1997-03-07 2003-01-23 The Procter & Gamble Company Catalysts and methods for catalytic oxidation
ZA981883B (en) * 1997-03-07 1998-09-01 Univ Kansas Catalysts and methods for catalytic oxidation
MA24594A1 (fr) * 1997-03-07 1999-04-01 Procter & Gamble Compositions de blanchiment
US20080125344A1 (en) * 2006-11-28 2008-05-29 Daryle Hadley Busch Bleach compositions
US20050187126A1 (en) * 2002-08-27 2005-08-25 Busch Daryle H. Catalysts and methods for catalytic oxidation
US6565828B2 (en) 2000-04-07 2003-05-20 Bristol-Myers Squibb Company Macrocyclic chelants for metallopharmaceuticals
EP1322626B1 (en) * 2000-09-29 2008-11-05 Anormed Inc. Process for preparation of n-1 protected n ring nitrogen containing cyclic polyamines and products thereof
DE10117242C1 (de) * 2001-04-06 2002-05-16 Schering Ag Unsymmetrische dimere Metallkomplexe, Liganden für diese Metallkomplexe, Verfahren zu deren Herstellung, Arzneimittel bzw. Diagnosemittel, die die Metallkomplexe enthalten, insbesondere Kontrastmittel
US6987102B2 (en) * 2001-07-31 2006-01-17 Anormed, Inc. Methods to mobilize progenitor/stem cells
US20040048763A1 (en) * 2002-08-27 2004-03-11 The Procter & Gamble Co. Bleach compositions
EP1637524A1 (en) * 2004-09-20 2006-03-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. 10-substituted 1-, 4, 7,-tris (carboxymethyl)-1,4,7,10-tetraazacyclo-dodecane derivative for use as contrast agents
TWI429404B (zh) * 2008-03-03 2014-03-11 Senomyx Inc 異山梨醇衍生物及彼等作為風味改良劑、促味劑及促味增強劑之用途
JP5735791B2 (ja) * 2010-12-07 2015-06-17 住友化学株式会社 金属錯体を含む素子
FR2968999B1 (fr) 2010-12-20 2013-01-04 Guerbet Sa Nanoemulsion de chelate pour irm
US10918742B2 (en) 2016-03-25 2021-02-16 Nanoprobes, Inc. Iodine-based particles
CN108779082B (zh) * 2016-04-13 2022-08-02 伯拉考成像股份公司 造影剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53144592A (en) * 1977-05-19 1978-12-15 Tabuse Iwao 122alkyll1*4*7*100tetrazacyclotridecane
US5198208A (en) * 1987-07-16 1993-03-30 Nycomed Imaging As Aminopolycarboxylic acids and derivatives thereof
DE3728525A1 (de) * 1987-08-24 1989-03-16 Schering Ag Mehrkernige substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
BR8907277A (pt) * 1988-12-22 1991-03-26 Dow Chemical Co Processo para preparar poliazamacrociclos mono-n-alquilados

Also Published As

Publication number Publication date
NO923673D0 (no) 1992-09-22
FR2672051A1 (fr) 1992-07-31
EP0499501B1 (fr) 1998-08-19
MX9200319A (es) 1992-07-01
DE69226669T2 (de) 1999-04-15
DE69226669D1 (de) 1998-09-24
AU1256292A (en) 1992-08-27
US5374416A (en) 1994-12-20
NZ241356A (en) 1995-02-24
EP0499501A2 (fr) 1992-08-19
JPH05504361A (ja) 1993-07-08
CZ290992A3 (en) 1993-02-17
JPH0735381B2 (ja) 1995-04-19
HU9203029D0 (en) 1992-12-28
HUT70023A (en) 1995-09-28
IL100717A (en) 1996-06-18
CZ281225B6 (cs) 1996-07-17
WO1992012978A1 (fr) 1992-08-06
KR960014355B1 (ko) 1996-10-15
EP0499501A3 (fr) 1992-08-26
FR2672051B1 (fr) 1993-05-21
ZA92470B (en) 1993-07-23
CA2078983A1 (fr) 1992-07-25
IL100717A0 (en) 1992-09-06
ATE169916T1 (de) 1998-09-15
AU650325B2 (en) 1994-06-16
IE920204A1 (en) 1992-07-29

Similar Documents

Publication Publication Date Title
NO923673D0 (no) Nye nitrogencykliske ligander, fremgangsmaate for deres fremstilling, polymetallkomplekser og et diagnostisk og terapeutisk preparat
DE69019584D1 (de) Makrocyclische Stickstoffliganden Verfahren zu ihrer Herstellung, ihre Metallkomplexe, sie enthaltende Diagnostische und therapeutische Mittel.
Holman et al. Comparison of magnetic resonance imaging studies with enzymatic indexes of myocardial necrosis for quantification of myocardial infarct size
DE3855239T2 (de) Aminocarbonsäure und Derivate
ES2626582T5 (es) Formulación de producto de contraste y su procedimiento de preparación asociado
IL109852A0 (en) Iodinated paramagnetic chelates
ES2593127T9 (es) Proceso para preparar una formulación farmacéutica de agentes de contraste
JP2860157B2 (ja) 腎機能測定用の既放射能標識テクネチウムキレート注射剤の製造方法
US4027005A (en) Diagnostic agents
AU8945891A (en) Technetium-99m complexes for use as radiopharmaceuticals
JPH04154729A (ja) 磁気共鳴造影剤
EP1355913A4 (en) COMPOUNDS BASED ON PARAMAGNETIC METAL COMPLEXES AND PHTALOCYANINE AND CONTRAST AGENT COMPRISING THESE COMPOUNDS
CN109770937A (zh) 一种心内科用可自动调整位置的心脏造影手术装置
EP1719754B1 (en) Metal complexes of DTPA derivatives , and radiation source including the metal complexes
GR3023954T3 (en) Derivated dtpa complexes, pharmaceuticals containing these compounds, their use as nmr- and radiographic contrasting agents and process for producing the same.
Fleay 99mTc‐Labelled EDTA for Renal Scanning
WO1995014678A1 (de) 1,4,7,10-tetraazacyclododecan-derivate, deren verwendung, diese enthaltende pharmazeutische mittel und verfahren zu deren herstellung
Michell et al. Angiography of the coronary circulation in living dogs using timed diastolic injections
SUD et al. Radioiodine uptake following thyroidectomy for thyroid cancer: Recurrence or ectopic tissue?
Tully et al. Renal scan prior to renal biopsy—a method of renal localization
MALLARD Some call it laziness: I call it deep thought (with apologies to Garfield)
Park Competition and the Role of Technology: An Assessment of the Medical Equipment Industry
Kopp et al. Radiation Protection in the intra-and post-operative diagnosis of the sentinel lymph node (SLN)
Klein et al. Massive pulmonary emboli diagnosed and followed in progress by lung imaging and radionuclide pulmonary angiography
Slivka et al. Detection of porencephaly by cerbral dynamic scanning